Standout Papers

Cholangiocarcinoma: Current Knowledge and New Develop... 2008 2026 2014 2020 534
  1. Cholangiocarcinoma: Current Knowledge and New Developments (2016)
    Boris Blechacz Gut and Liver
  2. Cholangiocarcinoma (2008)
    Boris Blechacz, Gregory J. Gores Hepatology
  3. Clinical diagnosis and staging of cholangiocarcinoma (2011)
    Boris Blechacz, Mina Komuta et al. Nature Reviews Gastroenterology & Hepatology

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy
2024 Standout
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
2024 Standout
2 intermediate papers

Works of Boris Blechacz being referenced

Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis
2018
Sorafenib inhibits signal transducer and activator of transcription‐3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2†
2009
and 1 more

Author Peers

Author Last Decade Papers Cites
Boris Blechacz 1819 416 813 1233 35 3.2k
Seiji Satoh 1292 257 1813 898 75 4.1k
Stuart A.C. McDonald 966 199 1134 894 61 3.0k
George Elia 1271 194 1625 1215 42 3.7k
Sumera I. Ilyas 3117 312 1234 1781 54 4.4k
G. J. A. Offerhaus 2804 818 1181 2488 75 5.3k
Kay Washington 1886 1737 1094 2246 74 5.5k
Rebecca Harrison 1455 526 528 510 63 2.6k
Frank A. Mitros 1335 649 895 810 92 3.8k
Melissa P. Upton 1575 616 1916 1479 118 5.6k
Marco Novelli 2206 854 1672 1597 61 6.0k

All Works

Loading papers...

Rankless by CCL
2026